"We are working on one proposal to bring all the departments or government agencies which deals with the pharma sector under one single department," Minister of Chemicals and Fertilisers Ananth Kumar said.
Explaining the rationale behind the move, he said: "At present, for research, licensing, patent and pricing of drugs or medicines there is a different department for each, so if all these come under one department there will be better co-ordination and effectiveness."
The Central Drugs Standard Control Organisation, under the Ministry of Health and Family Welfare, has regulatory control over import of drugs, approval of new drugs, clinical trials and approval of certain licences. It ensures safety, efficacy and quality of drugs, cosmetics and medical devices.
Kumar also said the government was also working on a comprehensive pharma policy that will address issued related to bulk drugs, medical implants and devices with an aim to drive growth in the sector.
"We are working on a comprehensive pharma policy to usher growth in this sector. Under this policy we are focusing on three areas-- bulk drugs, medical implants and medical devices," the minister said.
Kumar added: "For medical implants and devices we are working on how to increase their domestic production and to reduce imports."
The Indian pharma sector is Rs 1.8 lakh crore in size as on today.
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app